Clinical Trial Update: A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/phase 2 clinical trial evaluating SHR-A2102 in combination with Adebrelimab (with or without other antitumor therapy) for advanced or metastatic non-s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• SHR-A2102

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Advanced or Metastatic Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING